Target intelligence / Profile preview

DnaJ homolog subfamily B member 12 (DNAJB12) (DNAJB12)

Target
DNAJB12
Molecular classification
Chaperone, Heat shock protein 40 (Hsp40) family, DnaJ domain-containing protein
01

Overview

DnaJ homolog subfamily B member 12 (DNAJB12) is an endoplasmic reticulum (ER)-resident co-chaperone belonging to the Hsp40 family [1]. It functions primarily by recruiting Hsp70 chaperones to nascent or misfolded polypeptides, facilitating their proper folding or directing them toward ER-associated degradation (ERAD) [1, 3]. In the context of viral pathogenesis, DNAJB12 has been identified as a critical host factor for the Hepatitis B virus (HBV), where it assists in the assembly and secretion of both infectious virions and non-infectious subviral particles (SVPs) [2]. It specifically interacts with HBV surface proteins (HBsAg) to ensure their correct maturation and exit from the ER [3]. Because the secretion of HBsAg is a hallmark of chronic HBV infection and contributes to immune exhaustion, DNAJB12 is considered a potential host-targeting therapeutic target [2, 3]. Targeting this protein could reduce the viral burden and restore immune responses, although the essential role of DNAJB12 in cellular protein quality control poses a challenge for maintaining a favorable safety profile.

Other names
DNAJ antigen soluble 12DJB12ER-resident Hsp40 co-chaperone
02

Mechanism of action

DNAJB12 acts as a co-chaperone that facilitates the proper folding and assembly of Hepatitis B virus (HBV) surface proteins within the endoplasmic reticulum. By inhibiting DNAJB12, the maturation and subsequent secretion of subviral particles (SVPs) and infectious virions are disrupted, leading to a reduction in circulating viral antigens and viral load.

03

Biological functions

Protein foldingEndoplasmic reticulum-associated degradation (ERAD)Viral assembly and secretionProteostasis maintenance
04

Disease associations

Hepatitis B infectionViral infection
05

Safety considerations

Potential for systemic toxicity due to the essential role of DNAJB12 in endoplasmic reticulum-associated degradation (ERAD) and general protein quality controlRisk of inducing ER stress in non-infected cellsPossible interference with the folding of critical host proteins such as CFTR
06

Interacting drugs

Experimental RNA interference (RNAi) agents

1 more in the full profile.

07

Biomarkers

Hepatitis B surface antigen (HBsAg)HBV DNA levelsHBV RNA levels

Beyond the preview

Go deeper on DnaJ homolog subfamily B member 12 (DNAJB12) (DNAJB12).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DnaJ homolog subfamily B member 12 (DNAJB12) (DNAJB12).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call